AFP, primarily produced by the liver and yolk sac during fetal development, exhibits elevated levels in liver cancer due to various factors, including the release of AFP directly from the cancer cells or by the disruption of normal liver cellular function and, thereby, the leakage of AFP. The gene discussed is AFP; the disease is cancer.